SOURCE: Health Discovery Corporation

April 07, 2005 08:00 ET

Stephen D. Barnhill, M.D., Chairman and CEO of Health Discovery Corporation, to Present "New Validated Biomarker Discovery for Prostate Cancer and BPH" at Biomarkers Europe 2005 in London,

England

SAVANNAH, GA -- (MARKET WIRE) -- April 7, 2005 -- Health Discovery Corporation (OTC BB: HDVY) today announced that Dr. Stephen D. Barnhill, Chairman and CEO, will present "New Validated Biomarker Discovery for Prostate Cancer and BPH" at Biomarkers Europe 2005 on June 23, 2005 in London, England.

Stephen D. Barnhill, M.D., Chairman and CEO of Health Discovery Corporation, commented, "I am honored to be on the faculty of this very prestigious meeting focusing on the future integration of biomarkers in diagnostics and therapeutics." Dr. Barnhill continued, "I look forward to presenting Health Discovery Corporation's recent patent protected biomarker discoveries to this world renowned group of corporate and academic leaders."

More information on Biomarkers Europe 2005 can be found at http://healthdiscoverycorp.com/conferences/BiomarkerEurope.pdf

Health Discovery Corporation is a systems biology-oriented biomarker and pathway discovery company, which provides all aspects of First-Phase Biomarker Discovery(SM). The Company was established to provide pharmaceutical and diagnostic companies worldwide with newly discovered biomarkers used to create more accurate diagnostic tests, novel drug targets for more personalized medicines and new methods for detecting patients "at-risk" for toxicity-related events, thereby providing safer medications. Founded in September 2003, the Company is headquartered in Savannah, GA.

This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Acts of 1933 and Section 21E of the Securities Exchange Act of 1934. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove correct.

Contact Information